First Light Acquisition Group (FLAG) to Combine with Calidi Biotherapeutics, Inc. in $335M Deal

Jan 9, 2023 Deal Announcements & Amendments, Headline Post, INTEL by Nicholas Alan Clayton

First Light (FLAG) has entered into a definitive agreement to combine with Calidi Biotherapeutics at an enterprise value of $335 million. La Jolla, California-based Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that delivers oncolytic viruses for targeted therapy against difficult-to-treat cancers. The combined company is expected to trade on the NYSE American
Read More

To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

First Light Acquisition Group (FLAG) to Combine with Calidi Biotherapeutics, Inc. in $335M Deal

First Light Acquisition Group (FLAG) to Combine with Calidi Biotherapeutics, Inc. in $335M Deal

ByNicholas Alan Clayton